OpGen, Inc. Email Format
Biotechnology ResearchMaryland, United States11-50 Employees
OpGen, Inc. is a small biotechnology company based in Rockville, Maryland, that applies molecular microbiology to develop diagnostic tools for infectious diseases. Its work aims to guide antibiotic therapy decisions and support antibiotic stewardship to improve patient outcomes amid drug-resistant infections. The company develops multiplex diagnostic panels designed to identify multiple pathogens and resistance features, addressing antimicrobial resistance and reducing the spread of multidrug-resistant organisms. Described as a precision medicine firm, OpGen focuses on molecular diagnostics to assist clinicians and public health entities in managing infectious diseases. In 2024, OpGen appointed David Lazar as chief executive officer, marking a leadership change noted in industry coverage.